0001596584-14-000001.txt : 20140206 0001596584-14-000001.hdr.sgml : 20140206 20140205180714 ACCESSION NUMBER: 0001596584-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140206 DATE AS OF CHANGE: 20140205 EFFECTIVENESS DATE: 20140206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lumos Pharma, Inc. CENTRAL INDEX KEY: 0001596584 IRS NUMBER: 383830503 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-211391 FILM NUMBER: 14577363 BUSINESS ADDRESS: STREET 1: 515 CONGRESS AVENUE, SUITE 1800 CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 15124220155 MAIL ADDRESS: STREET 1: 515 CONGRESS AVENUE, SUITE 1800 CITY: AUSTIN STATE: TX ZIP: 78701 D 1 primary_doc.xml X0707 D LIVE 0001596584 Lumos Pharma, Inc. 515 CONGRESS AVENUE, SUITE 1800 AUSTIN TX TEXAS 78701 15124220155 DELAWARE None None Corporation true 2014 Richard John Hawkins 1701 Stamford Lane Austin TX TEXAS 78703 Executive Officer Director Promoter Jon S. Saxe 435 Old Oak Court Los Altos CA CALIFORNIA 94022 Executive Officer Director George Gilbert Cloyd 14107 Panorama Drive Austin TX TEXAS 78732 Director Kevin M. Lalande 401 Congress Avenue Suite 2950 Austin TX TEXAS 78701 Director Edward J Mathers 1954 Greenspring Drive Suite 600 Timonium MD MARYLAND 21093 Director Pharmaceuticals No Revenues 06b false 2014-01-24 false true false 45000 7500000 6500000 1000000 The issuer may accept up to an additional $1,000,000 in investment until April 24, 2014. false 3 0 0 1051186 This amount constitutes repayment of debt by the issuer to Mr. Hawkins and Mr. Saxe under promissory notes. false Lumos Pharma, Inc. Richard J. Hawkins Richard J. Hawkins Chief Executive Officer 2014-02-05